Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling

MLA

Szu-Yuan Wu, et al. “Low Molecular Weight Fucoidan Inhibits Hepatocarcinogenesis and Nonalcoholic Fatty Liver Disease in Zebrafish via ASGR/STAT3/HNF4A Signaling.” Clinical and Translational Medicine, vol. 10, Dec. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....828ec2eb23243a11b369e269414b0774&authtype=sso&custid=ns315887.

APA

Szu-Yuan Wu, Chun-Chia Cheng, Chiou-Hwa Yuh, Suat-Ming Chan, Bonifasius Putera Sampurna, Kuan-Hao Lin, & Wan-Yu Yang. (2020). Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling. Clinical and Translational Medicine, 10.

Chicago

Szu-Yuan Wu, Chun-Chia Cheng, Chiou-Hwa Yuh, Suat-Ming Chan, Bonifasius Putera Sampurna, Kuan-Hao Lin, and Wan-Yu Yang. 2020. “Low Molecular Weight Fucoidan Inhibits Hepatocarcinogenesis and Nonalcoholic Fatty Liver Disease in Zebrafish via ASGR/STAT3/HNF4A Signaling.” Clinical and Translational Medicine 10 (December). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....828ec2eb23243a11b369e269414b0774&authtype=sso&custid=ns315887.